Kanvas Biosciences Funding: $12M Raised, Pre-Series A (2023)
Kanvas Biosciences is a Biotech company based in Princeton, New Jersey. It has raised $12M in total funding. Latest round: Pre-Series A.
Kanvas Biosciences funding overview
Kanvas Biosciences is a Biotech company based in Princeton, New Jersey. Kanvas Biosciences has raised $12M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Pre-Series A announced in June 2023. The round record for Kanvas Biosciences runs through 2023; nothing later has been disclosed. Investors on record include DCVC, Lions Capital LLC, Cooke LLC, Uncommon Denominator, Triple Impact Capital. 5 distinct backers are named across the disclosed rounds.
Kanvas Biosciences at a glance
Total raised
$12M
Latest round
Pre-Series A
Latest round date
June 2023
Industry
Biotech
Headquarters
Princeton, New Jersey
Notable investors
DCVC, Lions Capital LLC, Cooke LLC, Uncommon Denominator, Triple Impact Capital
Frequently asked about Kanvas Biosciences funding
How much has Kanvas Biosciences raised?
Kanvas Biosciences has raised $12M in total disclosed funding across the rounds on record.
Who has invested in Kanvas Biosciences?
DCVC, Lions Capital LLC, Cooke LLC, Uncommon Denominator, Triple Impact Capital are named among the investors backing Kanvas Biosciences.
What was the latest Kanvas Biosciences funding round?
The most recent disclosed round is a Pre-Series A, announced in June 2023.
Where is Kanvas Biosciences based?
Kanvas Biosciences is based in Princeton, New Jersey.
What sector does Kanvas Biosciences operate in?
Kanvas Biosciences is tracked under Biotech from Princeton, New Jersey, with $12M in disclosed funding.
When did Kanvas Biosciences last raise?
The last disclosed Kanvas Biosciences round closed in June 2023 at Pre-Series A.
Totals shown for Kanvas Biosciences aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Princeton and the investors behind them below.
